irinotecan qilu pharma spain 20 mg/ml inf. opl. (conc.) i.v. flac.
qilu pharma spain s.l. - irinotecanhydrochloridetrihydraat 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentraat voor oplossing voor infusie - 20 mg/ml - irinotecanhydrochloridetrihydraat 20 mg/ml - irinotecan
irinotecan qilu pharma spain 20 mg/ml inf. opl. (conc.) i.v. flac.
qilu pharma spain s.l. - irinotecanhydrochloridetrihydraat 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentraat voor oplossing voor infusie - 20 mg/ml - irinotecanhydrochloridetrihydraat 20 mg/ml - irinotecan
irinotecan qilu pharma spain 20 mg/ml inf. opl. (conc.) i.v. flac.
qilu pharma spain s.l. - irinotecanhydrochloridetrihydraat 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentraat voor oplossing voor infusie - 20 mg/ml - irinotecanhydrochloridetrihydraat 20 mg/ml - irinotecan
irinotecan qilu pharma spain 20 mg/ml inf. opl. (conc.) i.v. flac.
qilu pharma spain s.l. - irinotecanhydrochloridetrihydraat 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentraat voor oplossing voor infusie - 20 mg/ml - irinotecanhydrochloridetrihydraat 20 mg/ml - irinotecan
tramvetol 50 mg tabletten voor honden
virbac sa - tramadolhydrochloride; tramadol - tablet - tramadolhydrochloride 50 mg/stuk; tramadol 43,9 mg/stuk, - tramadol - honden
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccins - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
librela
zoetis belgium - bedinvetmab - pijnstillers - honden - for the alleviation of pain associated with osteoarthritis in dogs.
prucalopride koanaa healthcare 1 mg filmomh. tabl.
koanaa healthcare spain s.l. - prucalopridesuccinaat 1,321 mg - eq. prucalopride 1 mg - filmomhulde tablet - 1 mg - prucalopridesuccinaat 1.321 mg - prucalopride
prucalopride koanaa healthcare 2 mg filmomh. tabl.
koanaa healthcare spain s.l. - prucalopridesuccinaat 2,642 mg - eq. prucalopride 2 mg - filmomhulde tablet - 2 mg - prucalopridesuccinaat 2.642 mg - prucalopride
nevanac
novartis europharm limited - nepafenac - pain, postoperative; ophthalmologic surgical procedures - ophthalmologica - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.